Literature DB >> 11735095

Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects.

P Ventura1, R Panini, C Verlato, G Scarpetta, G Salvioli.   

Abstract

Hyperhomocysteinemia (HHcy) is a metabolic disorder frequently occurring in the elderly population. Recently several reports have suggested abnormalities in homocysteine (tHcy) metabolism implicating HHcy as a metabolic link in the multifactorial processes characterizing many geriatric illnesses-with special emphasis on atherosclerotic vascular diseases and cognitive impairment. The present study was undertaken in a large sample of elderly hospitalized subjects to determine (1) the prevalence of HHcy, (2) the association of HHcy with vascular and cognitive disorders, and (3) the factors independently predicting Hhcy. Six hundred elderly subjects (264 men and 336 women; mean age, 79 +/- 9 years) were randomly chosen from those admitted as inpatients over a period of 3 years. In all patients, body mass index (BMI), mid-upper arm muscle area (MUAMA), plasma cholesterol, triglycerides, total proteins, albumin, lymphocyte count, creatinine, homocysteine (fasting and 4 hours after methionine oral load), serum vitamin B(6), vitamin B(12), and folate concentrations were measured. The presence of disease or use of medications known to affect homocysteine plasma levels were also recorded. The mean fasting tHcy level was 16.8 +/- 12 micromol/L in the whole sample, 18.18 +/- 13.25 micromol/L in men, and 15.86 +/- 12.14 micromol/L in women (P =.005 men v women). The mean Hcy level 4 hours after methionine load was 37.95 +/- 20.9 in the whole sample. Prevalence of hyperhomocysteinemia (fasting Hcy > or = 15 micromol/L or 4 hours after methionine load > or = 35 micromol/L) was 61% (365/600) (67% in men and 56% in women, P <.05). HHcy was rarely (8%) an isolated disorder; in addition to diabetes (20%), renal failure (48.2%), and malnutrition (20.2%), it was often associated with heart failure (30%), malignancies (20.5%), and the use of diuretics (56%) and anticonvulsant drugs (13%). Plasma homocysteine progressively increases across subjects from those with no diabetes, malnutrition, renal failure, obesity, inflammatory bowel disease, heart failure to those with 1, 2, or more concurrent diseases. Multiple stepwise regression analysis showed that 72% of plasma total fasting tHcy variability was explained by age, serum folate, plasma albumin, use of diuretics, and renal function (measured as plasma creatinine clearance). In conclusion, the present study documents that hyperhomocysteinemia, in elderly hospitalized patients is (1) a common finding, (2) frequently associated with vascular and cognitive disorders, and (3) probably a secondary phenomenon in most cases. The major predictor of high plasma homocysteine levels were age, serum folate, plasma albumin, plasma creatinine clearance, and use of diuretic drugs. These variables explain a large proportion of plasma Hcy variability. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735095     DOI: 10.1053/meta.2001.28079

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

Review 1.  The aging kidney: a review--part II.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Total serum homocysteine levels do not identify cognitive dysfunction in multimorbid elderly patients.

Authors:  S Hengstermann; G Laemmler; A Hanemann; A Schweter; E Steinhagen-Thiessen; A Lun; R-J Schulz
Journal:  J Nutr Health Aging       Date:  2009-02       Impact factor: 4.075

3.  Associations between medication use and homocysteine levels in an older population, and potential mediation by vitamin B12 and folate: data from the B-PROOF Study.

Authors:  Annelies C Ham; Anke W Enneman; Suzanne C van Dijk; Sadaf Oliai Araghi; Karin M A Swart; Evelien Sohl; Janneke P van Wijngaarden; Nikita L van der Zwaluw; Elske M Brouwer-Brolsma; Rosalie A M Dhonukshe-Rutten; Natasja M van Schoor; Tischa J M van der Cammen; M Carola Zillikens; Robert de Jonge; Paul Lips; Lisette C P G M de Groot; Joyce B J van Meurs; André G Uitterlinden; Renger F Witkamp; Bruno H C Stricker; Nathalie van der Velde
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

Review 4.  Homocysteine and cognitive function in elderly people.

Authors:  Angeles Garcia; Katherine Zanibbi
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

5.  Total serum homocysteine levels do not identify cognitive dysfunction in multimorbid elderly patients.

Authors:  S Hengstermann; G Laemmler; A Hanemann; A Schweter; E Steinhagen-Thiessen; A Lun; R-J Schulz
Journal:  J Nutr Health Aging       Date:  2008 Jun-Jul       Impact factor: 4.075

6.  Prognostic value of homocysteine and highly sensitive cardiac troponin T in children with acute heart failure.

Authors:  Doaa El-Amrousy; Samir Hassan; Hossam Hodeib
Journal:  J Saudi Heart Assoc       Date:  2017-12-02

7.  Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson's Disease.

Authors:  Megan C Bakeberg; Alexa Jefferson; Maddeson Riley; Michelle Byrnes; Soumya Ghosh; Frank L Mastaglia; Malcom K Horne; Sarah McGregor; Rick Stell; Jade Kenna; Sue Walters; Dana Hince; Ryan S Anderton
Journal:  Parkinsons Dis       Date:  2019-05-29

8.  The MTHFR 677T allele may influence the severity and biochemical risk factors of Alzheimer's disease in an Egyptian population.

Authors:  Nasser Attia Elhawary; Doaa Hewedi; Arwa Arab; Salwa Teama; Hassan Shaibah; Mohammed Taher Tayeb; Neda Bogari
Journal:  Dis Markers       Date:  2013-10-01       Impact factor: 3.434

9.  Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration.

Authors:  Sadullah Keles; Orhan Ates; Baki Kartal; Hamit Hakan Alp; Metin Ekinci; Erdinc Ceylan; Osman Ondas; Eren Arpali; Semih Dogan; Kenan Yildirim; Mevlut Sait Keles
Journal:  Clin Ophthalmol       Date:  2014-08-25

10.  Vitamin Status and the Development of Postoperative Cognitive Decline in Elderly Surgical Oncologic Patients.

Authors:  Linda B M Weerink; Barbara L van Leeuwen; Sofie A M Gernaat; Anthony R Absalom; Monique G Huisman; Hanneke van der Wal-Huisman; Gerbrand J Izaks; Geertruida H de Bock
Journal:  Ann Surg Oncol       Date:  2017-10-20       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.